← Evidence map

ReviewPharmacogenomics and personalized medicine2014

Finally sofosbuvir: an oral anti-HCV drug with wide performance capability.

Zeid Kayali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25540594